Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelink, Acumen, Adaptimmune, Annovis, Apollomics, Atyr, Bridge, Centessa, Cybin, Galera, Huidagene, Kintara, Lianbio, Mindbio, Nimbus, Nouscom, Novelmed, Sarepta, Spyglass, UCB, Ultimovacs, Vaccinex, YS.